Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Pharmaceutical Industry Statistics For The First Five Months Of 2009

This article was originally published in PharmAsia News

Executive Summary

Guotai Junan Securities, a Chinese securities company, recently issued a report on the country's pharmaceutical industry statistics for the first five months of 2009. The industry's total revenue and profit respectively reached RMB 322 billion ($47 billion) and RMB 30.9 billion, growing 18 percent compared to the same period last year. The profit growth rate ranked fourth in the country's 11 consumer goods industries. In terms of different industry segments, the revenue of chemical raw materials, formulations, patent TCM, and biopharmaceuticals increased 5.57 percent, 25.9 percent, 16.7 percent and 12.6 percent, respectively. The two largest sectors - chemical formulations and TCM - enjoyed a strong performance; chemical raw materials and biopharmaceuticals showed average results; while hygiene materials, TCM slices and veterinary drugs saw rapid growth. (Click here for more - Chinese Language)

Guotai Junan Securities, a Chinese securities company, recently issued a report on the country's pharmaceutical industry statistics for the first five months of 2009. The industry's total revenue and profit respectively reached RMB 322 billion ($47 billion) and RMB 30.9 billion, growing 18 percent compared to the same period last year. The profit growth rate ranked fourth in the country's 11 consumer goods industries. In terms of different industry segments, the revenue of chemical raw materials, formulations, patent TCM, and biopharmaceuticals increased 5.57 percent, 25.9 percent, 16.7 percent and 12.6 percent, respectively. The two largest sectors - chemical formulations and TCM - enjoyed a strong performance; chemical raw materials and biopharmaceuticals showed average results; while hygiene materials, TCM slices and veterinary drugs saw rapid growth. (Click here for more - Chinese Language)

"Guotai Junan Releases Pharmaceutical Industry Statistics For The First Five Months Of 2009" - cnstock.com (7/2/09)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel